跳至主要内容
临床试验/RBR-9kkjvnj
RBR-9kkjvnj尚未招募Unknown

Pharmaceutical intervention to optimize the use of inhalation devices in asthma patients: a randomized, open clinical tirial

niversidade Federal do Rio Grande do Norte0 个研究点开始时间: 2023年10月27日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Both sexes. Aged 18 years or older. Confirmed diagnosis of Asthma through spirometry. Patients currently using or starting the use of a dry powder inhaler (Aerolizer, Turbuhaler) and/or inhalation solution (Respimat system) on D0. Informed and voluntary consent to participate in the clinical trial

排除标准

  • Conditions that may influence the learning of the inhalation technique (psychiatric, neurological, or rheumatological disorders). Presence of respiratory diseases other than asthma. Ongoing viral or bacterial respiratory infection. Dependency on third parties for DI handling. Hearing impairment. Severe visual impairment. Treatment with a different DI other than Aerolizer, Turbuhaler, and Respimat. Active smoking. Undergoing respiratory physiotherapy

研究者

发起方
niversidade Federal do Rio Grande do Norte

相似试验

暂停
不适用
Optimization of the pharmacological component using additive placeboeffects: Is it possible to enhance the psychological component during self-medication by disclosing information about the psychological componentsself-medication: participants using a specific analgesic (ibuprofen, paracetamol, aspirin) for pain relief self-medication: participants using a specific antihistamine (dimetindene, loratadine, cetirizine) for itch relief
DRKS00009506niversitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Anästhesiologie108
已完成
不适用
Pharmacists' review of medicine during admission to hospitalIn-hospital adverse drug eventsOther complications of surgical and medical care, not elsewhere classified
ISRCTN08043800Region Zealand Hospital Pharmacy (Region Sjaelland Sygehusapoteket) (Denmark)648
招募中
不适用
Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient carelow adherence, problems with drug application/use, patients' concerns regarding their drug therapy
DRKS00026088Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik100
尚未招募
不适用
Aproach to optimize the dose of contrasut medicum considering patient's blood flow on CTA.
JPRN-UMIN000027046Ryukyu unversity hospital50
招募中
不适用
self-care economic evaluation of patients with type 2 diabetes mellitusType 2 Diabetes Mellitusdiabetes complicationsC19.246.099C18.452.394.750.149
RBR-6t4qmnniversidade Federal São João Del-Rei